Dare we hope for a “perfect storm” in anatabine?
The Trump administration, in the hope of lowering drug prices, is considering letting drugs go to market as soon as they are proven safe. Anatabine, under those circumstances, could easily go to market as an anti-inflammatory, having been taken by at least several hundred thousand individuals, including myself, during the 3 years it was available as Anatabloc, as well as the standard safety testing completed by Rock Creek.
NukeJohn in InvestorsHub/RCPI message #27546 said “If the company is forced into bankruptcy, I would imagine Dr. Mullan will be forced to sell the patents to the highest bidder”. “Perhaps the best approach would be to sell the rights to the patents one illness at a time to individual big pharmas”.
Here’s hoping that this is how the bankruptcy will turn out! Certainly this is what the major creditors and stockholders should be demanding!
